Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC02306 is a long intergenic non-coding RNA (lincRNA) gene that produces a non-coding RNA transcript, meaning it does not encode a protein but may influence gene regulation, chromatin dynamics, or transcription in a cell-type-specific manner. LincRNAs are generally longer than 200 nucleotides, and do not overlap protein-coding genes; they can modulate transcription, RNA stabilization, or chromatin architecture, often in a highly tissue-specific way. LINC02306 is annotated in human single-cell transcriptomic datasets as being expressed in certain excitatory neurons of the cerebral cortex, but its precise functional role, disease relevance, or therapeutic targeting potential has not been established in the available literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2306 (LINC02306).